Tag: COVID-19
-
Nation & World
Reasons so many teachers joining Great Resignation
Experts at HGSE webinar say districts, schools could offer educators more support to slow departure of teachers.
-
Nation & World
‘Endemic’ is not an exit
Harvard’s William Hanage, an epidemiologist and associate professor at the Harvard T.H. Chan School of Public Health, outlines what an endemic SARS-CoV-2 might look like.
-
Nation & World
Brain inflammation may strike the uninfected
New study reveals that living through the COVID-19 pandemic may trigger brain inflammation that contributes to fatigue, concentration difficulties, and depression.
-
Nation & World
The politics behind ineffective COVID treatments
Across the U.S., prescriptions of hydroxychloroquine and ivermectin increased in the latter part of 2020, most significantly in counties with the highest share of people voting Republican.
-
Nation & World
New page in pandemic playbook
Risk assessment experts offer tips for balancing pandemic risks, as government restrictions ease.
-
Nation & World
Hints of a long COVID wave as Omicron fades
As Omicron fades, specialists seek answers for patients who can’t shake symptoms.
-
Nation & World
The COVID treatment that missed its target
“Monoclonal antibodies should first go to patients at the highest risk of death from COVID-19, but the opposite happened …, ” says a Harvard Chan School researcher.
-
Nation & World
A world tour with David Damrosch
David Damrosch, chair of the Comparative Literature Department, revised pandemic-era essays into “Around the World in 80 Books.”
-
Nation & World
Is Omicron really ‘milder’? Not exactly.
The “milder” outcomes of Omicron are likely due to more population immunity rather than the virus’ properties, according to new research.
-
Nation & World
Hanage and other scientists keep close watch on Omicron subvariant
As Omicron rapidly recedes, some countries are seeing a new version of the variant, dubbed BA.2
-
Nation & World
Omicron optimism and shift from pandemic to endemic
With Omicron on the decline in some states, pandemic experts permit themselves hope, at least for the near term.
-
Nation & World
Why do more men die of COVID? It’s likely not what you think
Sex differences in COVID death rates vary by state and across time, suggesting social factors play a role.
-
Nation & World
Harvard advisers on Omicron surge, shifting protocols
Leading experts offer insights as case numbers surge to record highs nationwide and new in-person semester nears.
-
Nation & World
‘Schools should not close’
Harm to kids and families outweighs COVID risks, says Harvard Chan School expert Joe Allen.
-
Nation & World
Study holds warning on pandemic drinking
A one-year increase in alcohol consumption in the U.S. during the COVID-19 pandemic is estimated to cause 8,000 additional deaths from alcohol-related liver disease by 2040.
-
Nation & World
Remdesivir-resistant COVID case sets off few alarms
Harvard Med specialist says cases of remdesivir-resistant disease seem rare, may not become big issue.
-
Nation & World
Fauci speaks to the perilous moment in Harvard Chan School lecture
At Harvard, Anthony Fauci outlined early Omicron findings and urged more robust efforts to bring the pandemic under control, including global vaccination.
-
Nation & World
Scientists race to define Omicron threat, worried about ‘surge upon a surge’
Early findings on immune escape and transmissibility, combined with danger posed by Delta, heighten urgency of vaccination, testing, other safety measures.
-
Nation & World
2 early vaccination surveys worse than worthless thanks to ‘big data paradox,’ analysts say
As governments and health officials navigate pandemic, researchers stress the danger that comes with bad information.
-
Nation & World
Time of day matters when getting vaccine
An observational study finds that antibody levels are higher when health care workers received the SARS-CoV-2 vaccine in the afternoon.
-
Nation & World
‘This virus is a shape-shifter’
A new study led by Harvard researchers models future SARS-CoV-2 mutations and forecasts their ability to evade immune defenses developed by vaccines and antibody-based treatments.
-
Nation & World
Omicron ‘astonishing to behold,’ says Hanage
With Omicron landing in the U.S. this week, Harvard epidemiologist William Hanage reviewed what we know and the many things still unknown about the fast-moving coronavirus variant.
-
Nation & World
Vaccine reduces transmission in breakthrough cases
Breakthrough COVID-19 cases in vaccinated people may be less likely to spread infection because virus is shed for a shorter period of time as opposed to infections in unvaccinated people.
-
Nation & World
How Omicron variant could affect University protocols
Harvard professors and advisory group members detail where things stand and where they might go.
-
Nation & World
Keeping an eye on Omicron
Mary Bushman, a research fellow in the Department of Epidemiology at Harvard Chan School, co-authored a recent paper that modeled variant threats.
-
Nation & World
Breaking down boosters
A Harvard expert shares insight on the science and history of vaccine boosters and why we need them, speculating on a future that includes periodic COVID boosters.
-
Nation & World
Long COVID sufferers face physical pain, physician skepticism
Long COVID’s laundry list of ills include skepticism and doubt often conveyed in the doctors’ office.
-
Nation & World
Repurposing a familiar drug for COVID-19
New research points to a well-known and widely available drug called disulfiram (marketed as Antabuse) as a possible treatment for COVID-19.
-
Nation & World
Potential fixes for COVID-related GI issues
A human Intestine Chip has helped identify drugs that can target GI symptoms associated with both the common cold and SARS-CoV-2 virus infections.
-
Nation & World
Vaccine side effects or a doctor carrying COVID?
A new decision-support tool helped preserve the health care workforce by distinguishing symptoms associated with COVID-19 vaccinations from symptoms of the virus itself.